Heidelberg Innovation PresseHeidelberg Innovation - einer der führenden deutschen Venture-Capital-Gesellschaften im Bereich der Life Sciences
http://www.hd-innovation.de/en/presse/
Santhera Reports 2010 Interim Financial Results with Significat Reduction in Net Loss and Strong Increase in Product Sales
http://www.hd-innovation.de/en/presse/?id=538
2010-09-03Santhera and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease
http://www.hd-innovation.de/en/presse/?id=535
2010-09-03Biofrontera AG closes placement of capital increase
http://www.hd-innovation.de/en/presse/?id=533
2010-09-03Cellzome's CEO Tim Edwards new Chairman of UK's BioIndustry Association
http://www.hd-innovation.de/en/presse/?id=534
2010-09-02Biofrontera files European drug application for BF-200 ALA
http://www.hd-innovation.de/en/presse/?id=532
2010-09-01Biofrontera AG reports half-year financial results for 2010
http://www.hd-innovation.de/en/presse/?id=531
2010-08-31Santhera Obtains European Patent for Use of Catena/Sovrima in the Treatment of Muscular Dystrophies
http://www.hd-innovation.de/en/presse/?id=526
2010-08-13Biofrontera received manufacturing and distribution license
http://www.hd-innovation.de/en/presse/?id=523
2010-08-13Biorfontera AG decides on capital increase
http://www.hd-innovation.de/en/presse/?id=521
2010-08-04Digilab Introduces Identity Raman Reader into Asian Market
http://www.hd-innovation.de/en/presse/?id=525
2010-07-16